3vvn - Revision history

OCA at 08:42, 20 March 2024

OCA — Wed, 20 Mar 2024 08:42:30 GMT

←Older revision		Revision as of 08:42, 20 March 2024
Line 3:		Line 3:
	<StructureSection load='3vvn' size='340' side='right'caption='[[3vvn]], [[Resolution\|resolution]] 2.40Å' scene=''>		<StructureSection load='3vvn' size='340' side='right'caption='[[3vvn]], [[Resolution\|resolution]] 2.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3vvn]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/~~Pyrfu Pyrfu~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3VVN FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3vvn]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Pyrococcus_furiosus_DSM_3638 Pyrococcus furiosus DSM 3638]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3VVN FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat" id="~~ligandDat~~">~~<scene name='pdbligand=OLC:(2R)~~-2~~,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene>~~</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.398Å</td></tr>
-	<tr id='~~related~~'><td class="sblockLbl"><b>[[~~Related_structure~~\|~~Related~~:]]</b></td><td class="sblockDat"><~~div style~~='~~overflow~~: ~~auto; max~~-~~height: 3em;'>[[3vvo\|3vvo]]~~, ~~[[3vvp\|3vvp]], [[3vvq\|3vvq]], [[3vvr\|3vvr]], [[3vvs\|3vvs]]</div></td></tr>~~	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene></td></tr>
-	~~<tr id='gene~~'>~~<td class="sblockLbl"><b>[[Gene\|Gene:]]~~</b>~~</td><td class="sblockDat">PF0708 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=186497 PYRFU])~~</td></tr>	+
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3vvn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vvn OCA], [https://pdbe.org/3vvn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3vvn RCSB], [https://www.ebi.ac.uk/pdbsum/3vvn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3vvn ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3vvn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vvn OCA], [https://pdbe.org/3vvn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3vvn RCSB], [https://www.ebi.ac.uk/pdbsum/3vvn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3vvn ProSAT]</span></td></tr>
	</table>		</table>
-	~~<div style~~=~~"background-color:#fffaf0;">~~	+	== Function ==
-	=~~= Publication Abstract from PubMed~~ ==	+	[https://www.uniprot.org/uniprot/Q8U2X0_PYRFU Q8U2X0_PYRFU]
-	Multidrug and toxic compound extrusion (MATE) family transporters are conserved in the three primary domains of life (Archaea, Bacteria and Eukarya), and export xenobiotics using an electrochemical gradient of H(+) or Na(+) across the membrane. MATE transporters confer multidrug resistance to bacterial pathogens and cancer cells, thus causing critical reductions in the therapeutic efficacies of antibiotics and anti-cancer drugs, respectively. Therefore, the development of MATE inhibitors has long been awaited in the field of clinical medicine. Here we present the crystal structures of the H(+)-driven MATE transporter from Pyrococcus furiosus in two distinct apo-form conformations, and in complexes with a derivative of the antibacterial drug norfloxacin and three in vitro selected thioether-macrocyclic peptides, at 2.1-3.0 A resolutions. The structures, combined with functional analyses, show that the protonation of Asp 41 on the amino (N)-terminal lobe induces the bending of TM1, which in turn collapses the N-lobe cavity, thereby extruding the substrate drug to the extracellular space. Moreover, the macrocyclic peptides bind the central cleft in distinct manners, which correlate with their inhibitory activities. The strongest inhibitory peptide that occupies the N-lobe cavity may pave the way towards the development of efficient inhibitors against MATE transporters.	+
-		+
-	Structural basis for the drug extrusion mechanism by a MATE multidrug transporter.,Tanaka Y, Hipolito CJ, Maturana AD, Ito K, Kuroda T, Higuchi T, Katoh T, Kato HE, Hattori M, Kumazaki K, Tsukazaki T, Ishitani R, Suga H, Nureki O Nature. 2013 Apr 11;496(7444):~~247-51. doi: 10.1038~~/~~nature12014. Epub 2013 Mar 27. PMID:23535598<ref>PMID:23535598<~~/~~ref>~~	+
-		+
-	~~From MEDLINE®/PubMed®, a database of the U~~.S. ~~National Library of Medicine.<br>~~	+
-	</~~div>~~	+
-	~~<div class="pdbe-citations 3vvn" style="background-color:#fffaf0;"></div>~~	+
-	~~== References ==~~	+
-	~~<references~~/>	+
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Pyrfu~~]]	+	[[Category: Pyrococcus furiosus DSM 3638]]
-	[[Category: Ishitani, R]]	+	[[Category: Ishitani R]]
-	[[Category: Nureki, O]]	+	[[Category: Nureki O]]
-	[[Category: Tanaka, Y]]	+	[[Category: Tanaka Y]]
-	~~[[Category: Mate]]~~	+
-	~~[[Category: Multidrug transporter]]~~	+
-	~~[[Category: Transport protein~~]]	+

OCA at 19:06, 27 July 2022

OCA — Wed, 27 Jul 2022 19:06:36 GMT

←Older revision		Revision as of 19:06, 27 July 2022
Line 1:		Line 1:

	==Crystal structure of MATE in the straight conformation==		==Crystal structure of MATE in the straight conformation==
-	<StructureSection load='3vvn' size='340' side='right' caption='[[3vvn]], [[Resolution\|resolution]] 2.40Å' scene=''>	+	<StructureSection load='3vvn' size='340' side='right'caption='[[3vvn]], [[Resolution\|resolution]] 2.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3vvn]] is a 1 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/Pyrfu Pyrfu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=3VVN FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3vvn]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Pyrfu Pyrfu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3VVN FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene></td></tr>
-	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3vvo\|3vvo]], [[3vvp\|3vvp]], [[3vvq\|3vvq]], [[3vvr\|3vvr]], [[3vvs\|3vvs]]</td></tr>	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[3vvo\|3vvo]], [[3vvp\|3vvp]], [[3vvq\|3vvq]], [[3vvr\|3vvr]], [[3vvs\|3vvs]]</div></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PF0708 ([~~http~~://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=186497 PYRFU])</td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PF0708 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=186497 PYRFU])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=3vvn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vvn OCA], [~~http~~://pdbe.org/3vvn PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=3vvn RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/3vvn PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=3vvn ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3vvn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vvn OCA], [https://pdbe.org/3vvn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3vvn RCSB], [https://www.ebi.ac.uk/pdbsum/3vvn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3vvn ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 22:		Line 22:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Pyrfu]]		[[Category: Pyrfu]]
	[[Category: Ishitani, R]]		[[Category: Ishitani, R]]

OCA at 18:50, 11 August 2016

OCA — Thu, 11 Aug 2016 18:50:51 GMT

←Older revision		Revision as of 18:50, 11 August 2016
Line 1:		Line 1:
		+
	==Crystal structure of MATE in the straight conformation==		==Crystal structure of MATE in the straight conformation==
	<StructureSection load='3vvn' size='340' side='right' caption='[[3vvn]], [[Resolution\|resolution]] 2.40Å' scene=''>		<StructureSection load='3vvn' size='340' side='right' caption='[[3vvn]], [[Resolution\|resolution]] 2.40Å' scene=''>
Line 6:		Line 7:
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3vvo\|3vvo]], [[3vvp\|3vvp]], [[3vvq\|3vvq]], [[3vvr\|3vvr]], [[3vvs\|3vvs]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3vvo\|3vvo]], [[3vvp\|3vvp]], [[3vvq\|3vvq]], [[3vvr\|3vvr]], [[3vvs\|3vvs]]</td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PF0708 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=186497 PYRFU])</td></tr>		<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PF0708 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=186497 PYRFU])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3vvn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vvn OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3vvn RCSB], [http://www.ebi.ac.uk/pdbsum/3vvn PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3vvn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vvn OCA], [http://pdbe.org/3vvn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3vvn RCSB], [http://www.ebi.ac.uk/pdbsum/3vvn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3vvn ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 3vvn" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 10:26, 4 January 2015

OCA — Sun, 04 Jan 2015 10:26:45 GMT

←Older revision		Revision as of 10:26, 4 January 2015
Line 1:		Line 1:
-	~~{{STRUCTURE_3vvn\| PDB=3vvn \| SCENE= }}~~	+	==Crystal structure of MATE in the straight conformation==
-	===Crystal structure of MATE in the straight conformation===	+	<StructureSection load='3vvn' size='340' side='right' caption='[[3vvn]], [[Resolution\|resolution]] 2.40Å' scene=''>
-	~~{{ABSTRACT_PUBMED_23535598}}~~	+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[3vvn]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Pyrfu Pyrfu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3VVN FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3vvo\|3vvo]], [[3vvp\|3vvp]], [[3vvq\|3vvq]], [[3vvr\|3vvr]], [[3vvs\|3vvs]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PF0708 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=186497 PYRFU])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3vvn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vvn OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3vvn RCSB], [http://www.ebi.ac.uk/pdbsum/3vvn PDBsum]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Multidrug and toxic compound extrusion (MATE) family transporters are conserved in the three primary domains of life (Archaea, Bacteria and Eukarya), and export xenobiotics using an electrochemical gradient of H(+) or Na(+) across the membrane. MATE transporters confer multidrug resistance to bacterial pathogens and cancer cells, thus causing critical reductions in the therapeutic efficacies of antibiotics and anti-cancer drugs, respectively. Therefore, the development of MATE inhibitors has long been awaited in the field of clinical medicine. Here we present the crystal structures of the H(+)-driven MATE transporter from Pyrococcus furiosus in two distinct apo-form conformations, and in complexes with a derivative of the antibacterial drug norfloxacin and three in vitro selected thioether-macrocyclic peptides, at 2.1-3.0 A resolutions. The structures, combined with functional analyses, show that the protonation of Asp 41 on the amino (N)-terminal lobe induces the bending of TM1, which in turn collapses the N-lobe cavity, thereby extruding the substrate drug to the extracellular space. Moreover, the macrocyclic peptides bind the central cleft in distinct manners, which correlate with their inhibitory activities. The strongest inhibitory peptide that occupies the N-lobe cavity may pave the way towards the development of efficient inhibitors against MATE transporters.

-	~~==About this Structure==~~	+	Structural basis for the drug extrusion mechanism by a MATE multidrug transporter.,Tanaka Y, Hipolito CJ, Maturana AD, Ito K, Kuroda T, Higuchi T, Katoh T, Kato HE, Hattori M, Kumazaki K, Tsukazaki T, Ishitani R, Suga H, Nureki O Nature. 2013 Apr 11;496(7444):247-51. doi: 10.1038/nature12014. Epub 2013 Mar 27. PMID:23535598<ref>PMID:23535598</ref>
-	~~[[3vvn]] is~~ a ~~1 chain structure with sequence from [http://en~~.~~wikipedia~~.~~org/wiki/Pyrfu Pyrfu]~~. ~~Full crystallographic information is available from [http~~:/~~/oca~~.~~weizmann~~.~~ac.il~~/~~oca-bin/ocashort?id=3VVN OCA].~~	+

-	==~~Reference~~==	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	~~<ref group="xtra">PMID:023535598</ref>~~<references ~~group="xtra"~~/><~~references~~/>	+	</div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
	[[Category: Pyrfu]]		[[Category: Pyrfu]]
-	[[Category: Ishitani, R.]]	+	[[Category: Ishitani, R]]
-	[[Category: Nureki, O.]]	+	[[Category: Nureki, O]]
-	[[Category: Tanaka, Y.]]	+	[[Category: Tanaka, Y]]
	[[Category: Mate]]		[[Category: Mate]]
	[[Category: Multidrug transporter]]		[[Category: Multidrug transporter]]
	[[Category: Transport protein]]		[[Category: Transport protein]]

OCA at 06:31, 29 January 2014

OCA — Wed, 29 Jan 2014 06:31:26 GMT

←Older revision		Revision as of 06:31, 29 January 2014
Line 1:		Line 1:
	{{STRUCTURE_3vvn\| PDB=3vvn \| SCENE= }}		{{STRUCTURE_3vvn\| PDB=3vvn \| SCENE= }}
	===Crystal structure of MATE in the straight conformation===		===Crystal structure of MATE in the straight conformation===
		+	{{ABSTRACT_PUBMED_23535598}}

	==About this Structure==		==About this Structure==
-	[[3vvn]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/~~Pyrococcus_furiosus_dsm_3638 Pyrococcus furiosus dsm 3638~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA].	+	[[3vvn]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Pyrfu Pyrfu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA].
-	[[Category: ~~Pyrococcus furiosus dsm 3638~~]]	+
		+	==Reference==
		+	<ref group="xtra">PMID:023535598</ref><references group="xtra"/><references/>
		+	[[Category: Pyrfu]]
	[[Category: Ishitani, R.]]		[[Category: Ishitani, R.]]
	[[Category: Nureki, O.]]		[[Category: Nureki, O.]]

OCA at 01:39, 4 April 2013

OCA — Thu, 04 Apr 2013 01:39:02 GMT

←Older revision		Revision as of 01:39, 4 April 2013
Line 1:		Line 1:
-	~~'''Unreleased~~ structure~~'''~~	+	{{STRUCTURE_3vvn\| PDB=3vvn \| SCENE= }}
		+	===Crystal structure of MATE in the straight conformation===

-	~~The entry~~ 3vvn is ~~ON HOLD until Paper Publication~~	+	==About this Structure==
-		+	[[3vvn]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Pyrococcus_furiosus_dsm_3638 Pyrococcus furiosus dsm 3638]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VVN OCA].
-	~~Authors~~: ~~Tanaka, Y.,~~ Ishitani, R., Nureki, O.	+	[[Category: Pyrococcus furiosus dsm 3638]]
-		+	[[Category: Ishitani, R.]]
-	~~Description~~: ~~Crystal structure of archaeal~~ protein	+	[[Category: Nureki, O.]]
		+	[[Category: Tanaka, Y.]]
		+	[[Category: Mate]]
		+	[[Category: Multidrug transporter]]
		+	[[Category: Transport protein]]

OCA at 04:39, 12 September 2012

OCA — Wed, 12 Sep 2012 04:39:39 GMT

←Older revision		Revision as of 04:39, 12 September 2012
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 3vvn is ON HOLD	+	The entry 3vvn is ON HOLD until Paper Publication

	Authors: Tanaka, Y., Ishitani, R., Nureki, O.		Authors: Tanaka, Y., Ishitani, R., Nureki, O.

	Description: Crystal structure of archaeal protein		Description: Crystal structure of archaeal protein

OCA: Protected "3vvn" [edit=sysop:move=sysop]

OCA — Wed, 01 Aug 2012 05:15:26 GMT

Protected "3vvn" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:15, 1 August 2012

OCA: New page: '''Unreleased structure''' The entry 3vvn is ON HOLD Authors: Tanaka, Y., Ishitani, R., Nureki, O. Description: Crystal structure of archaeal protein

OCA — Wed, 01 Aug 2012 05:15:25 GMT

New page: '''Unreleased structure''' The entry 3vvn is ON HOLD Authors: Tanaka, Y., Ishitani, R., Nureki, O. Description: Crystal structure of archaeal protein

New page

'''Unreleased structure'''

The entry 3vvn is ON HOLD

Authors: Tanaka, Y., Ishitani, R., Nureki, O.

Description: Crystal structure of archaeal protein